Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mudit Kakar

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Pharmaceutical Research|September 14, 2006
Controlling protein compartmentalization to overcome diseaseJames R Davis, Mudit Kakar, Carol S Lim
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 19, 2007
Optimizing the protein switch: altering nuclear import and export signals, and ligand binding domainMudit Kakar, James R Davis, Steve E Kern, et al.
Pharmaceutical Research|June 15, 2007
Signal sequences for targeting of gene therapy products to subcellular compartments: the role of CRM1 in nucleocytoplasmic shuttling of the protein switchMudit Kakar, Amy B Cadwallader, James R Davis, et al.
The AAPS Journal|January 20, 2007
Geldanamycin, an inhibitor of Hsp90, blocks cytoplasmic retention of progesterone receptors and glucocorticoid receptors via their respective ligand binding domainsMudit Kakar, Charu Kanwal, J Rian Davis, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 7, 2009
Controlling subcellular localization to alter function: Sending oncogenic Bcr-Abl to the nucleus causes apoptosisAndrew S Dixon, Mudit Kakar, Korbinian M H Schneider, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Pharmaceutical Research|September 14, 2006
Controlling protein compartmentalization to overcome diseaseJames R Davis, Mudit Kakar, Carol S Lim
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 19, 2007
Optimizing the protein switch: altering nuclear import and export signals, and ligand binding domainMudit Kakar, James R Davis, Steve E Kern, et al.
Pharmaceutical Research|June 15, 2007
Signal sequences for targeting of gene therapy products to subcellular compartments: the role of CRM1 in nucleocytoplasmic shuttling of the protein switchMudit Kakar, Amy B Cadwallader, James R Davis, et al.
The AAPS Journal|January 20, 2007
Geldanamycin, an inhibitor of Hsp90, blocks cytoplasmic retention of progesterone receptors and glucocorticoid receptors via their respective ligand binding domainsMudit Kakar, Charu Kanwal, J Rian Davis, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 7, 2009
Controlling subcellular localization to alter function: Sending oncogenic Bcr-Abl to the nucleus causes apoptosisAndrew S Dixon, Mudit Kakar, Korbinian M H Schneider, et al.
Pageof 1